Holly Martinez Interviewed by The Portland Business Journal—Why Psilocybin Should Not Be A Schedule 1 Drug

Holly Martinez was interviewed by the Portland Business Journal for a Q&A feature article covering why psilocybin should not be a Schedule 1 drug. Holly, a litigation lawyer, is a member of a firm legal team representing a Seattle doctor in a case that is seeking to get the Drug Enforcement Administration to reclassify psilocybin as a Schedule 2 drug.

Click here to read the full article in the Portland Business Journal.